TY - JOUR
T1 - Further dissection of the functional heterogeneity within the OKT 4 + and OKT8 + human T cell subsets
AU - Thomas, Y.
AU - Rogozinski, L.
AU - Rothman, P.
AU - Rabbani, L. E.
AU - Andrews, S.
AU - Irigoyen, O. H.
AU - Chess, L.
PY - 1982
Y1 - 1982
N2 - Previous studies have suggested functional heterogeneity within the OKT4 + and the OKT8 + populations. For example, after activation the OKT4 + population contains not only helper cells but also cells capable of suppressing B cell differentiation. Previous studies also indicate that the reciprocal T cell population, OKT8 +, does not provide helper activity but contains cytotoxic effector cells and radiosensitive cells important in the suppression of B cell differentiation. Using a new differentiation antigen, OKT17, which recognizes a surface antigen present on the majority of resting normal peripheral T lymphocytes but is present only on a subset of OKT4 + cells after activation, evidence was obtained that two functionally mature subsets can be distinguished within the OKT4 + population itself: OKT4 +17 + radiosensitive suppressor cells and OKT4 +17 - radiosensitive helper cells. Recently, another monoclonal antibody, OKT20, has been described which is present on a small percentage of resting lymphocytes but is expressed in varying proportions on activated T cells. Functional analysis of normal resting human T lymphocytes demonstrated that the OKT20-depleted T cell subset was able to generate cytotoxic cells and to suppress antibody production to the same extent as did OKT8 + cells. On the other hand, when unselected T lymphocytes were cultured for six days in a mixed lymphocyte reaction and then depleted of OKT20 reactive cells, the cytotoxic effector T cells were eliminated. In contrast, OKT20-depleted T cells after identical activation were still able to suppress antibody production. These data provide evidence that following activation of OKT8 + cells, the OKT20 differentiation antigen becomes selectively expressed on cytotoxic effectors but not on suppressor cells.
AB - Previous studies have suggested functional heterogeneity within the OKT4 + and the OKT8 + populations. For example, after activation the OKT4 + population contains not only helper cells but also cells capable of suppressing B cell differentiation. Previous studies also indicate that the reciprocal T cell population, OKT8 +, does not provide helper activity but contains cytotoxic effector cells and radiosensitive cells important in the suppression of B cell differentiation. Using a new differentiation antigen, OKT17, which recognizes a surface antigen present on the majority of resting normal peripheral T lymphocytes but is present only on a subset of OKT4 + cells after activation, evidence was obtained that two functionally mature subsets can be distinguished within the OKT4 + population itself: OKT4 +17 + radiosensitive suppressor cells and OKT4 +17 - radiosensitive helper cells. Recently, another monoclonal antibody, OKT20, has been described which is present on a small percentage of resting lymphocytes but is expressed in varying proportions on activated T cells. Functional analysis of normal resting human T lymphocytes demonstrated that the OKT20-depleted T cell subset was able to generate cytotoxic cells and to suppress antibody production to the same extent as did OKT8 + cells. On the other hand, when unselected T lymphocytes were cultured for six days in a mixed lymphocyte reaction and then depleted of OKT20 reactive cells, the cytotoxic effector T cells were eliminated. In contrast, OKT20-depleted T cells after identical activation were still able to suppress antibody production. These data provide evidence that following activation of OKT8 + cells, the OKT20 differentiation antigen becomes selectively expressed on cytotoxic effectors but not on suppressor cells.
UR - http://www.scopus.com/inward/record.url?scp=0020457111&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020457111&partnerID=8YFLogxK
M3 - Article
C2 - 6215426
AN - SCOPUS:0020457111
SN - 0271-9142
VL - 2
SP - 8S-14S
JO - Journal of Clinical Immunology
JF - Journal of Clinical Immunology
IS - Suppl. 3
ER -